Hologic

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging.[2]

Hologic
Public
Traded as
ISINUS4364401012 Edit this on Wikidata
IndustryMedical devices
Founded1985[1]
Headquarters,
Key people
Number of employees
6,478[1][2] (2019)
Websitewww.hologic.com

In late November 2013, activist investor Carl Icahn disclosed a 12.5% stake in the company. Subsequently, the company adopted a poison pill to prevent a hostile takeover. In negotiations with the Company's board of directors, two additional directors backed by Mr. Icahn were added to the board, each managing directors of Icahn holding companies.[3] Icahn considered his investment and intervention into Hologic to have been a success, with his nominees to the board of directors resigning on March 3, 2016[4] and exiting his position by May 16, 2016.[5]

In 2017, Hologic acquired Westford, Massachusetts-based aesthetic medicine company Cynosure for $1.65 billion.[6]

On November 20, 2019, Hologic announced the divestment of Cynosure to Clayton, Dubilier & Rice for $205 million;[7] this was completed on December 30, 2019.[8] Cynosure had ~825 employees at the time of the divestiture.[9][6]

In March 2020, Hologic received emergency use authorization from the FDA for a test for 2019-nCoV to help mitigate the COVID-19 pandemic.[10]

ReferencesEdit

  1. ^ a b "Hologic, Inc. (HOLX)". Yahoo! Finance. Retrieved January 11, 2020.
  2. ^ a b c d e "Hologic Inc. Profile". MarketWatch.com. Retrieved January 11, 2020.
  3. ^ Grover, Natalie (December 9, 2013). "Hologic names new CEO, adds two Icahn nominees to board". Reuters.com. Archived from the original on October 1, 2018.
  4. ^ Adams, Dan (March 4, 2016). "Carl Icahn cashes in on Hologic success". Boston Globe. Archived from the original on September 3, 2019. Retrieved January 6, 2020.
  5. ^ Witkowski, Wallace (May 6, 2016). "Icahn exits Gannett, Hologic positions; adds to Xerox". MarketWatch.com. Archived from the original on July 5, 2017. Retrieved January 6, 2020.
  6. ^ a b Stempniak, Marty (January 3, 2020). "Breast imaging company Hologic unloads aesthetics line at $1B-plus loss". RadiologyBusiness.com. Archived from the original on January 6, 2020. Retrieved January 5, 2020.
  7. ^ "Hologic to Sell Cynosure Medical Aesthetics Business to Clayton, Dubilier & Rice". BusinessWire.com. November 20, 2019. Retrieved January 11, 2020.
  8. ^ "Hologic Completes Divestiture of Cynosure Medical Aesthetics Business". Yahoo! Finance. Business Wire. December 30, 2019. Retrieved January 5, 2020.
  9. ^ "Hologic (HOLX) Divests Cynosure to Focus on Women's Health". Zacks.com. January 2, 2020. Archived from the original on January 6, 2020. Retrieved January 5, 2020.
  10. ^ "FDA Approves Abbott Laboratories Coronavirus Test, Company To Ship 150,000 Kits". IBTimes.com. 19 March 2020. Archived from the original on 20 March 2020.

External linksEdit